List your company

Regression on Diabetic Retinopathy

0.1519P90 DeltaFedeKD
0.0774160.5801831.082951.585717May 7, 2026

Evaluation results

MethodLinks
FedeKDalpha=0.52026.050.1519—
FedeKDalpha=0.32026.050.1551—
FedeKDalpha=0.12026.050.168—
FedAvgalpha=0.52026.050.3413—
FedProxalpha=0.52026.050.3458—
FedAvgalpha=0.32026.050.3658—
FedProxalpha=0.32026.050.3686—
FedAvgalpha=0.12026.050.4217—
FedProxalpha=0.12026.050.4231—
FedDynalpha=0.52026.051.1125—
FedDynalpha=0.32026.051.2947—
FedDynalpha=0.12026.052.014—
FedAvgalpha=0.1, Agg. Method=FedAvg2026.05—0.1216
FedAvgalpha=0.3, Agg. Method=FedAvg2026.05—0.1682
FedAvgalpha=0.5, Agg. Method=FedAvg2026.05—0.1507
FedDynalpha=0.1, Agg. Method=FedDyn2026.05—1.3174
FedDynalpha=0.3, Agg. Method=FedDyn2026.05—0.7513
FedDynalpha=0.5, Agg. Method=FedDyn2026.05—0.6559
FedeKDalpha=0.1, Agg. Method=FedAvg, Model=FedeKD2026.05—0.0606
FedeKDalpha=0.3, Agg. Method=FedAvg, Model=FedeKD2026.05—0.005
FedeKDalpha=0.5, Agg. Method=FedAvg, Model=FedeKD2026.05—0.0058
FedProxalpha=0.1, Agg. Method=FedProx2026.05—0.1248
FedProxalpha=0.3, Agg. Method=FedProx2026.05—0.17
FedProxalpha=0.5, Agg. Method=FedProx2026.05—0.1506